![]() |
JOURNAL TOOLS |
Opzioni di pubblicazione |
eTOC |
Per abbonarsi |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Publication history |
Estratti |
Permessi |
Per citare questo articolo |
Share |


I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
COMMENTARY COVID-19 SECTION Open access
Italian Journal of Emergency Medicine 2021 April;10(1):30-3
DOI: 10.23736/S2532-1285.21.00084-7
Copyright © 2021 THE AUTHORS
This is an open access article distributed under the terms of the CC BY-NC-ND 4.0 license which allows users to copy and distribute the manuscript, as long as this is not done for commercial purposes and further does not permit distribution of the manuscript if it is changed or edited in any way, and as long as the user gives appropriate credits to the original author(s) and the source (with a link to the formal publication through the relevant DOI) and provides a link to the license.
lingua: Inglese
Clinical indications for anti-COVID-19 antibodies use
Luigi PETRAMALA 1, 2 ✉, Giuliana GUERRIZIO 3, Marianna CALABRETTO 3, Massimo GENTILE 4 Sapienza MEU Group
1 Department of Emergency, Critical Areas and Trauma, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy; 2 Department of Translational and Precision Medicine, Sapienza University, Rome, Italy; 3 Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy; 4 Department of Molecular Medicine, Sapienza University, Rome, Italy